ASSOCIATION BETWEEN TREATMENT-RESISTANT KIDNEY-ALLOGRAFT REJECTION AND POST-TRANSPLANT APPEARANCE OF ANTIBODIES TO DONOR B-LYMPHOCYTE ALLOANTIGENS